Literature DB >> 16283135

[Mitral regurgitation].

F A Flachskampf1, W G Daniel.   

Abstract

Mitral regurgitation is the second most frequent reason for valve surgery. The most important causes of mitral regurgitation are degenerative valve disease (mitral valve prolapse), left ventricular impairment and dilatation (in coronary artery disease or dilated cardiomyopathy), and infective endocarditis. The regurgitation of blood from the left ventricle into the left atrium leads to dilatation of the left atrium, increase in pulmonary capillary pressure and pulmonary congestion. In chronic severe mitral regurgitation, the left ventricle dilates and becomes impaired over time. Key symptoms are fatigue and dyspnea on exertion. The most prominent physical sign is the characteristic systolic murmur. Echocardiography identifies severity, delineates morphology, and estimates the impact of mitral regurgitation on left ventricular function. Importantly, echocardiography identifies candidates for mitral valve repair. Symptomatic patients and asymptomatic patients with impaired left ventricular function should be operated. If possible, valve repair is preferred over valve replacement to better preserve left ventricular function and to avoid the need for postoperative anticoagulation (except if atrial fibrillation persists).

Entities:  

Mesh:

Year:  2006        PMID: 16283135     DOI: 10.1007/s00108-005-1529-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  17 in total

1.  Cardiac surgery in Germany during 2003: a report by the German Society for Thoracic and Cardiovascular Surgery.

Authors:  P Kalmár; E Irrgang
Journal:  Thorac Cardiovasc Surg       Date:  2004-10       Impact factor: 1.827

2.  Clinical outcome of mitral regurgitation due to flail leaflet.

Authors:  L H Ling; M Enriquez-Sarano; J B Seward; A J Tajik; H V Schaff; K R Bailey; R L Frye
Journal:  N Engl J Med       Date:  1996-11-07       Impact factor: 91.245

3.  Effects of carvedilol on left ventricular mass, chamber geometry, and mitral regurgitation in chronic heart failure.

Authors:  B D Lowes; E A Gill; W T Abraham; J R Larrain; A D Robertson; M R Bristow; E M Gilbert
Journal:  Am J Cardiol       Date:  1999-04-15       Impact factor: 2.778

4.  Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography.

Authors:  D Y Leung; B P Griffin; W J Stewart; D M Cosgrove; J D Thomas; T H Marwick
Journal:  J Am Coll Cardiol       Date:  1996-11-01       Impact factor: 24.094

5.  Cardiac valve surgery--the "French correction".

Authors:  A Carpentier
Journal:  J Thorac Cardiovasc Surg       Date:  1983-09       Impact factor: 5.209

6.  Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)

Authors:  J P Singh; J C Evans; D Levy; M G Larson; L A Freed; D L Fuller; B Lehman; E J Benjamin
Journal:  Am J Cardiol       Date:  1999-03-15       Impact factor: 2.778

7.  The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema.

Authors:  Luc A Piérard; Patrizio Lancellotti
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

8.  Determinants of exercise-induced changes in mitral regurgitation in patients with coronary artery disease and left ventricular dysfunction.

Authors:  Patrizio Lancellotti; Frédéric Lebrun; Luc A Piérard
Journal:  J Am Coll Cardiol       Date:  2003-12-03       Impact factor: 24.094

9.  Intraoperative Doppler color flow mapping for decision-making in valve repair for mitral regurgitation. Technique and results in 100 patients.

Authors:  W J Stewart; P J Currie; E E Salcedo; B W Lytle; C C Gill; W A Schiavone; D A Agler; D M Cosgrove
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

10.  Durability of mitral valve repair for degenerative disease.

Authors:  A M Gillinov; D M Cosgrove; E H Blackstone; R Diaz; J H Arnold; B W Lytle; N G Smedira; J F Sabik; P M McCarthy; F D Loop
Journal:  J Thorac Cardiovasc Surg       Date:  1998-11       Impact factor: 5.209

View more
  1 in total

1.  Case Report: Good cardiac tolerance to Toripalimab in a CVD patient with oral melanoma.

Authors:  Wei Pan; Li Yin; Yadi Guo; Dachao Pan; Hui Huang
Journal:  Front Pharmacol       Date:  2022-08-01       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.